Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
Finding a long-term cure for tumor patients still represents a major challenge. Immunotherapies offer promising therapy options, since they are designed to specifically prime the immune system against the tumor and modulate the immunosuppressive tumor microenvironment. Using nucleic-acid-based vacci...
Main Authors: | Jenny Schunke, Volker Mailänder, Katharina Landfester, Michael Fichter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/15/12174 |
Similar Items
-
Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials
by: Veena Vijayan, et al.
Published: (2019-10-01) -
PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets
by: Maximilian Brückner, et al.
Published: (2022-08-01) -
Research progress of nanovaccine in anti-tumor immunotherapy
by: Min Yao, et al.
Published: (2023-08-01) -
Self-adjuvanting cancer nanovaccines
by: Zhiyun Liao, et al.
Published: (2022-07-01) -
Editorial: Deciphering immunological mechanisms of spatial and temporal vaccine delivery
by: Mingzhao Zhu, et al.
Published: (2024-02-01)